|
| |
|
Sify.com » Topics » BioCryst
BioCryst News
BioCryst elects ex-Glaxo and Squibb exec to board Flu drug maker BioCryst Pharmaceuticals Inc. said Wednesday it elected Charles Sanders to its board of directors.Sanders worked for five years as CEO of Glaxo Inc., which is now part of GlaxoSmithKline PLC, and was chairman of the Glaxo board for three years. He is also a former vice chairman of Squibb Corp., now part of Bristol-Myers Squibb Co. His appointment expands BioCryst's board to eight
BioCryst prices stock offering at $9.75 per share
Flu drug developer BioCryst Pharmaceuticals Inc. priced its 5 million common stock share offering at $9.75 per share.
BioCryst Pharma to sell up to 5.75M new shares
Flu drug developer BioCryst Pharmaceuticals Inc. said Tuesday it plans to sell as many as 5.75 million new shares of stock.
BioCryst receives $22.5 million peramivir order
BioCryst Pharmaceuticals Inc. said Thursday it will receive $22.5 million as part of a new contract with the Department of Health and Human Services over the intravenous flu treatment peramivir. |
|
|
© Copyright Sify Technologies Ltd, 1998-2011. All rights reserved. India News Portal, Sify.com hosted at SifyHosting India's first Level 3 Internet Data Centre. Site optimized for Internet Explorer 5.5 and above. See Disclaimer |Privacy Policy &Parental Guidance on pornography |careers@sify |About Us |Feedback |Advertise | |
